Home › Parkinson's Disease › North Carolina
Parkinson's Disease clinical trials in North Carolina
15 studies for Parkinson's Disease are looking for participants at sites in North Carolina.
Cities in North Carolina
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Wake Forest University School of Medicine, Winston-Salem
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT02071134Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Wake Forest University School of Medicine, Winston-Salem
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT03664609A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #067, Raleigh
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07804615Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
- Novant Health /ID# 278567, Charlotte
RecruitingObservational study
Ages 18 to 69 · All sexes · Updated Nov 10, 2026 · NCT07227896A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Asheville Neurology, Asheville
- Duke University Medical Center, Durham
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Nov 5, 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Duke Neurological Disorders Clinic, Durham
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Nov 2, 2026 · NCT06944522A Study of Buntanetap in Participants With PD
- Duke Department of Neurosurgery, Durham
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Oct 30, 2026 · NCT07284784A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of North Carolina - Chapel Hill, Chapel Hill
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Oct 30, 2026 · NCT06680830A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Asheville Neurology Specialists, P.A. (Site #229), Asheville
- Duke Neurological Disorders Clinic (Site #210), Durham
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Oct 28, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of North Carolina - Chapel Hill, Chapel Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015Apathy in Parkinson Disease TMS Study
- UNC-Chapel Hill, Cassidy Lab, Chapel Hill
Recruiting
Ages 55 to 80 · All sexes · Updated Jul 8, 2026 · NCT06087926Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease
- University of North Carolina at Chapel Hill, Chapel Hill
Recruiting
Ages 50 to 80 · All sexes · Updated Jun 25, 2026 · NCT05864157Use of CereGate Therapy for Freezing of Gait in PD
- Wake Forest University, Winston-Salem
Recruiting
Ages 21 to 80 · All sexes · Updated May 28, 2026 · NCT05292794Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT03233646A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Atrium Health Wake Forest Baptist Adult Neurology - Janeway Tower, Winston-Salem
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 24, 2025 · NCT06765668From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.